CVS Health reported $415.1B of revenue over the trailing twelve months, +7.4% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $415.1B (to Q2 2026). Net Income: $4.89B, trailing twelve months to Q2 2026. Free Cash Flow: $11.8B, trailing twelve months to Q2 2026. Op Margin: 2.0%, trailing twelve months to Q2 2026.

CVSCVS Health

HealthcareUSD

$94.30

$62.0152 weeks$110.58

CVS as reported

CVS Health reported $415.1B of revenue over the trailing twelve months, +7.4% on the year before. 11 reported series are charted on this page, each one as filed.

$415.1B

Revenue, trailing twelve months · to Q2 2026 · +7.4% against the twelve months before

Net Income: $4.89B
Net Income · +7.9% year on year · trailing twelve months to Q2 2026
Free Cash Flow: $11.8B
Free Cash Flow · +146% year on year · trailing twelve months to Q2 2026
Op Margin: 2.0%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for CVS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$415.1B	+7.4%	Q2 2026
Net Income	$4.89B	+7.9%	Q2 2026
EPS	$3.80	+5.8%	Q2 2026
Gross Margin	44%	n/a	Q2 2026
Op Margin	2.0%	n/a	Q2 2026
Net Margin	1.2%	n/a	Q2 2026
ROE	3.2%	n/a	Q2 2026
ROA	0.99%	n/a	Q2 2026
ROIC	3.7%	n/a	Q2 2026
Free Cash Flow	$11.8B	+146%	Q2 2026
P/E	24.8	n/a	today